相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ASEQ: fast allele-specific studies from next-generation sequencing data
Alessandro Romanel et al.
BMC MEDICAL GENOMICS (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Oncotator: Cancer Variant Annotation Tool
Alex H. Ramos et al.
HUMAN MUTATION (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
A basal stem cell signature identifies aggressive prostate cancer phenotypes
Bryan A. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Shusuke Akamatsu et al.
CELL REPORTS (2015)
Polycomb-mediated silencing in neuroendocrine prostate cancer
Pier-Luc Clermont et al.
CLINICAL EPIGENETICS (2015)
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
Himisha Beltran et al.
JAMA ONCOLOGY (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
Hsueh-Li Tan et al.
CLINICAL CANCER RESEARCH (2014)
Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis-A Systematic Review and Pooled Analysis
Hai Tao Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Eliezer M. Van Allen et al.
NATURE MEDICINE (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer
Lijuan Lin et al.
PLOS ONE (2014)
Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
Jean-Philippe P. Theurillat et al.
SCIENCE (2014)
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
Colin C. Pritchard et al.
NATURE COMMUNICATIONS (2014)
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
Dimple Chakravarty et al.
NATURE COMMUNICATIONS (2014)
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling
Neil Rajan et al.
ONCOTARGET (2014)
Unraveling the clonal hierarchy of somatic genomic aberrations
Davide Prandi et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
Meena Kanduri et al.
EPIGENETICS (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Epigenomic Alterations in Localized and Advanced Prostate Cancer
Pei-Chun Lin et al.
NEOPLASIA (2013)
Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
Juan Miguel Mosquera et al.
NEOPLASIA (2013)
Next-generation Prostate Cancer Biobanking: Toward a Processing Protocol Amenable for the International Cancer Genome Consortium
Raquel Esgueva et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2012)
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway
Hongbing Chen et al.
ENDOCRINE-RELATED CANCER (2012)
The Transcription Factor SPDEF Suppresses Prostate Tumor Metastasis
Joshua J. Steffan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
Himisha Beltran et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt
Jae Hyang Lim et al.
NATURE COMMUNICATIONS (2012)
Genome-wide DNA Methylation Events in TMPRSS2-ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
Stefan T. Boerno et al.
CANCER DISCOVERY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles
Altuna Akalin et al.
GENOME BIOLOGY (2012)
RSEQtools: a modular framework to analyze RNA-Seq data using compact, anonymized data summaries
Lukas Habegger et al.
BIOINFORMATICS (2011)
Pybedtools: a flexible Python library for manipulating genomic datasets and annotations
Ryan K. Dale et al.
BIOINFORMATICS (2011)
EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin-Dependent Hepatocarcinogenesis
Alfred S. L. Cheng et al.
CANCER RESEARCH (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
Andrea Sboner et al.
GENOME BIOLOGY (2010)
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Kyung Park et al.
NEOPLASIA (2010)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Karen E. Knudsen et al.
CLINICAL CANCER RESEARCH (2009)
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
Jing Chen et al.
NUCLEIC ACIDS RESEARCH (2009)
Shared TP53 Gene Mutation in Morphologically and Phenotypically Distinct Concurrent Primary Small Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Prostate
Donna E. Hansel et al.
PROSTATE (2009)
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines
Francesca Demichelis et al.
NUCLEIC ACIDS RESEARCH (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
Haley Hieronymus et al.
CANCER CELL (2006)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
CC Maley et al.
NATURE GENETICS (2006)
Small cell carcinoma of the prostate: An immunohistochemical study
Jorge L. Yao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
分享论文
